A multivariable model of ultrasound and biochemical parameters for predicting high-volume lymph node metastases of papillary thyroid carcinoma with Hashimoto's thyroiditis
- Xiao-Hui Liu 1, Hong-Qing Yin 1, Hong Shen 1, Xi-Ya Wang 1, Zheng Zhang 2, Xiao-Feng Yuan 1, Qi Tang 1, Jun Shao 1
- Xiao-Hui Liu 1, Hong-Qing Yin 1, Hong Shen 1
- 1Department of Ultrasound Diagnosis, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China.
- 2Department of Medical Ultrasound, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
- 0Department of Ultrasound Diagnosis, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new nomogram effectively predicts high-volume lymph node metastases in papillary thyroid cancer with Hashimoto's thyroiditis, aiding surgical planning. This tool combines ultrasound and clinicopathologic data for accurate risk assessment.
Area Of Science
- Oncology
- Radiology
- Pathology
Background
- Papillary thyroid carcinoma (PTC) frequently co-occurs with Hashimoto's thyroiditis.
- Predicting high-volume lymph node metastases (HVLNM) is crucial for effective PTC management.
- Current prediction methods for HVLNM in PTC with Hashimoto's thyroiditis require enhancement.
Purpose Of The Study
- To develop and validate a nomogram for predicting HVLNM in patients with PTC and Hashimoto's thyroiditis.
- To integrate ultrasound findings with clinicopathologic data for improved predictive accuracy.
- To provide a tool for pre-operative risk stratification and surgical planning.
Main Methods
- A retrospective study of 187 patients with PTC and Hashimoto's thyroiditis.
- Development of a predictive model using LASSO and logistic regression analysis.
- Validation of the nomogram using receiver operating characteristic (ROC) curves.
Main Results
- Four key predictors identified: tumor size, extrathyroidal extension, histological grade, and vascularity.
- The nomogram demonstrated strong predictive power in both training (AUC=0.914) and validation (AUC=0.889) sets.
- The developed nomogram is effective for clinical application.
Conclusions
- The nomogram effectively predicts HVLNM risk in PTC patients with Hashimoto's thyroiditis.
- This tool assists in tailoring surgical management and improving patient outcomes.
- The nomogram provides a valuable basis for pre-operative decision-making.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

